NewSquare Capital’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

NewSquare Capital’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-60	Closed	-$1	–	1302
2025 Q2	$1	Hold	60	–	–	﹤0.01%	1308
2025 Q1	$1	Hold	60	–	–	﹤0.01%	1161
2024 Q4	$1	Hold	60	–	–	﹤0.01%	912
2024 Q3	$0	Hold	60	–	–	﹤0.01%	387
2024 Q2	$2	Hold	60	–	–	﹤0.01%	352
2024 Q1	$5	Hold	60	–	–	﹤0.01%	436
2023 Q4	$6	Hold	60	–	–	﹤0.01%	488
2023 Q3	$14	Hold	60	–	–	﹤0.01%	590
2023 Q2	$16	Hold	60	–	–	﹤0.01%	839
2023 Q1	$11	Hold	60	–	–	﹤0.01%	876
2022 Q4	$12	Hold	60	–	–	﹤0.01%	818
2022 Q3	$0	Hold	60	–	–	﹤0.01%	488
2022 Q2	$0	Hold	60	–	–	﹤0.01%	430
2022 Q1	$0	Hold	60	–	–	﹤0.01%	480
2021 Q4	$0	Hold	60	–	–	﹤0.01%	406
2021 Q3	$0	Buy	+60	New	+$214	﹤0.01%	397

Other funds holding DNA.WS

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

NewSquare Capital's DNA.WS Position: Q3 2025 in Review

NewSquare Capital sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2025, closing a stake of 60 shares — an estimated $1 sold.

NewSquare Capital first reported a position in DNA.WS in Q3 2021 and held it in 16 quarters. The position peaked at $16 in Q2 2023. 1 fund tracked by Wall St. Rank holds DNA.WS as of Q3 2025.

NewSquare Capital reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2025 after selling out during the quarter.
NewSquare Capital sold 60 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2025, an estimated $1.
NewSquare Capital first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 16 quarters.
NewSquare Capital's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $16 in Q2 2023.
1 fund tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.